You have 4 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute-graft-versus-host Disease

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute GVHD Trial in Zhengzhou (Jaktinib Hydrochloride Tablets)

Not yet recruiting
  • Acute Graft-Versus-Host Disease
  • Jaktinib Hydrochloride Tablets
  • Zhengzhou, Henan, China
    Henan Tumor Hospital
Nov 29, 2021

Acute-graft-versus-host Disease Trial (ASC930)

Not yet recruiting
  • Acute-graft-versus-host Disease
  • ASC930
  • (no location specified)
Nov 16, 2021

Acute GVHD, Steroid Refractory GVHD Trial in Columbus (BRD4 Inhibitor PLX51107)

Recruiting
  • Acute Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • BRD4 Inhibitor PLX51107
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 24, 2022

Pediatric HSCT Recipients With aGVHD: Prospective Observational

Recruiting
  • Graft Versus Host Disease, Acute
  • Hematopoietic Stem Cell Transplantation
    • Trieste, Italy
      IRCCS Burlo Garofolo
    Apr 30, 2022

    Acute-graft-versus-host Disease Trial in Minneapolis (Ruxolitinib 10 MG Oral Tablet, hCG, Corticosteroids)

    Not yet recruiting
    • Acute-graft-versus-host Disease
    • Ruxolitinib 10 MG Oral Tablet
    • +2 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Nov 2, 2022

    Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)

    Recruiting
    • Safety and Efficacy
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Sep 27, 2023

    Steroid Resistant Acute GVHD Trial in Lyon (inolimomab)

    Available
    • Steroid Resistant Acute Graft Versus Host Disease
    • inolimomab
    • Lyon, France
      ElsaLys Biotech
    Sep 16, 2021

    Hyperbaric Oxygen Therapy, Acute-graft-versus-host Disease Trial in Jinan (Hyperbaric oxygen therapy)

    Recruiting
    • Hyperbaric Oxygen Therapy
    • Acute-graft-versus-host Disease
    • Hyperbaric oxygen therapy
    • Jinan, Shandong, China
      Shandong Provincial Hospital
    Oct 13, 2021

    Acute GVHD in Recipients of Hematopoietic Transplant

    Not yet recruiting
    • Graft-versus-host Disease
      • Sevilla, Seville, Spain
      • +8 more
      Jul 8, 2022

      Acute-graft-versus-host Disease Trial in Erlangen, Hamburg, Regensburg (Uvadex)

      Recruiting
      • Acute-graft-versus-host Disease
      • Erlangen, Germany
      • +2 more
      Oct 3, 2021

      Acute-graft-versus-host Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Suzhou (Sitagliptin + Standard

      Recruiting
      • Acute-graft-versus-host Disease
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • Sitagliptin + Standard Prophylaxis
      • Standard Prophylaxis
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University, Jiangsu Ins
      Jan 13, 2022

      Fecal Microbiota Transplantation in Gut aGVHD Treated

      Recruiting
      • Acute-graft-versus-host Disease
      • Fecal microbiota
      • Suzhou, Jiangsu, China
        中国
      Mar 26, 2022

      Hematologic Malignancies Trial in Milwaukee (Tildrakizumab)

      Recruiting
      • Hematologic Malignancies
      • Milwaukee, Wisconsin
        Froedtert Hospital and the Medical College of Wisconsin
      Sep 8, 2021

      Acute GVHD (Gvhd) Grade, Hematopoietic Cell Transplantation, Fecal Microbiota Transplant Trial in Boston (Fecal Microbiota

      Recruiting
      • Acute Graft-Versus-Host Disease (Gvhd) Grade
      • +2 more
      • Fecal Microbiota Transplant
      • Boston, Massachusetts
        Massachusetts General Hospital
      Sep 29, 2021

      Allogeneic Disease, GVH - Graft Versus Host Reaction, GVHD, Acute Trial in Paris (Methotrexate, Placebo)

      Recruiting
      • Allogeneic Disease
      • +3 more
      • Paris, France
        Saint Antoine Hospital - Hematology Department
      Oct 22, 2021

      Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in United States (drug, other, biological)

      Recruiting
      • Hematologic and Lymphocytic Disorder
      • Hematopoietic and Lymphoid Cell Neoplasm
      • Placebo Administration
      • +3 more
      • Duarte, California
      • +3 more
      Dec 14, 2022

      Acute-graft-versus-host Disease Trial in Beijing (XBI-302, XBI-302 Placebo)

      Recruiting
      • Acute-graft-versus-host Disease
      • XBI-302
      • XBI-302 Placebo
      • Beijing, China
        Bejing Goboard Boren Hospital
      May 4, 2022

      aGVHD, Stem Cell Transplant Complications Trial in Beijing (Ruxolitinib, Corticosteroid)

      Recruiting
      • aGVHD
      • Stem Cell Transplant Complications
      • Beijing, Beijing, China
        Chinese PLA General Hospital
      May 23, 2022

      Acute GVHD Trial in Spain (Adult Allogeneic Mesenchymal cells from adipose tissue.)

      Active, not recruiting
      • Acute Graft Versus Host Disease
      • Adult Allogeneic Mesenchymal cells from adipose tissue.
      • Pamplona, Navarra, Spain
      • +5 more
      Feb 1, 2022

      Acute GVHD in Intestine, Steroid Refractory GVHD Trial in France (MaaT013)

      Available
      • Acute Graft Versus Host Disease in Intestine
      • Steroid Refractory GVHD
      • Amiens, France
      • +19 more
      Jun 20, 2022

      Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

      Not yet recruiting
      • Graft Vs Host Disease
      • +5 more
      • CliniMACS® device
      • (no location specified)
      Jul 20, 2023

      GVHD Trial in Stanford (donor regulatory T lymphocytes, laboratory biomarker analysis)

      Suspended
      • Graft Versus Host Disease
      • donor regulatory T lymphocytes
      • laboratory biomarker analysis
      • Stanford, California
        Stanford University Hospitals and Clinics
      Aug 18, 2021

      Steroid-refractory Acute Graft-versus-host Disease Trial in Worldwide (MC0518, BAT)

      Recruiting
      • Steroid-refractory Acute Graft-versus-host Disease
      • MC0518
      • BAT
      • Amiens, France
      • +37 more
      Nov 1, 2022

      Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism Trial in Belgium, Netherlands (Mesenchymal stem

      Recruiting
      • Graft-versus-host Disease
      • +2 more
      • Mesenchymal stem cells
      • Edeghem, Antwerpen, Belgium
      • +11 more
      Sep 19, 2022

      Acute GVHD Trial in United States (natalizumab, steroids)

      Active, not recruiting
      • Acute Graft Versus Host Disease
      • Duarte, California
      • +11 more
      Oct 15, 2021